EFX Stock Surges 16% With A 5-day Winning Spree On Better-Than-Feared Earnings
Equifax (EFX) – a provider of credit information, fraud prevention, and analytics services – hit a 5-day winning streak, with cumulative gains over this period amounting to 16%. The company’s market cap has surged by about $3.4 Bil over the last 5 days and currently stands at $25 Bil.
The stock has YTD (year-to-date) return of 6.6% compared to 1.4% for S&P 500. This calls for a re-evaluation of the stock’s valuation to find out whether this is an opportunity or a trap.
What Triggered The Rally?
[1] Better-Than-Feared Q4 Earnings Report
- What Is Driving Biogen’s Recent Drop and What Comes Next
- Does Caterpillar Stock Still Have Room to Run?
- Cash Machine Trading Cheap – Centene Stock Set to Run?
- Can a $25B Investment Surge Sustain Micron’s 20% AI Memory Grab?
- The Hidden Dangers Facing Apple Stock
- How to Get Paid to Buy PYPL at a Steep Discount
- Q4 EPS beat of $2.09 vs $2.05 estimate
- Strong Q1 revenue guidance above consensus
- Impact: Reversal from 52-week low, Renewed institutional confidence
Opportunity or Trap?
Below is our take on valuation.
There is a near-equal mix of good and bad in EFX stock given its overall Moderate operating performance and financial condition. This is aligned with the stock’s Moderate valuation because of which we think it is Fairly Priced (For details, see Buy or Sell EFX).
But here is the real interesting point.
You are reading about this 16% move after it happened. The market has already priced in the news. To catch the next winner before the headlines, you need predictive signals, not notifications. Our High Quality Portfolio has flagged 5 new opportunities that have not surged yet.
Returns vs S&P 500
The following table summarizes the return for EFX stock vs. the S&P 500 index over different periods, including the current streak:
| Return Period | EFX | S&P 500 |
|---|---|---|
| 1D | 1.6% | -0.3% |
| 5D (Current Streak) | 15.8% | 0.3% |
| 1M (21D) | -10.7% | -0.4% |
| 3M (63D) | -2.1% | 3.2% |
| YTD 2026 | -6.6% | 1.4% |
| 2025 | -14.2% | 16.4% |
| 2024 | 3.7% | 23.3% |
| 2023 | 28.2% | 24.2% |
However, big gains can follow sharp reversals – but how has EFX behaved after prior drops? See EFX Dip Buyer Analysis to learn more.
Gains and Losses Streaks: S&P 500 Constituents
There are currently 132 S&P constituents with 3 days or more of consecutive gains and 16 constituents with 3 days or more of consecutive losses.
| Consecutive Days | # of Gainers | # of Losers |
|---|---|---|
| 3D | 99 | 7 |
| 4D | 12 | 4 |
| 5D | 8 | 1 |
| 6D | 9 | 3 |
| 7D or more | 4 | 1 |
| Total >=3 D | 132 | 16 |
Key Financials for Equifax (EFX)
Last 2 Fiscal Years:
| Metric | FY2023 | FY2024 |
|---|---|---|
| Revenues | $5.3 Bil | $5.7 Bil |
| Operating Income | $933.6 Mil | $1.0 Bil |
| Net Income | $545.3 Mil | $604.1 Mil |
Last 2 Fiscal Quarters:
| Metric | 2025 FQ2 | 2025 FQ3 |
|---|---|---|
| Revenues | $1.5 Bil | $1.5 Bil |
| Operating Income | $310.8 Mil | $264.3 Mil |
| Net Income | $191.3 Mil | $160.2 Mil |
While EFX stock looks attractive given its winning streak, investing in a single stock without detailed, thorough analysis can be risky. The Trefis High Quality (HQ) Portfolio, with a collection of 30 stocks, has a track record of comfortably outperforming its benchmark that includes all 3 — the S&P 500, S&P mid-cap, and Russell 2000 indices. Why is that? As a group, HQ Portfolio stocks provided better returns with less risk versus the benchmark index; less of a roller-coaster ride, as evident in HQ Portfolio performance metrics.